Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis

被引：0
|
作者：
Jian Luo
Ke Wang
Dan Liu
Bin-Miao Liang
Chun-Tao Liu
机构：
[1] Sichuan University,Department of Respiratory and Critical Care Medicine
[2] Sichuan University,Department of Critical Care Medicine, West China School of Medicine and West China Hospital
来源：
Respiratory Research | / 17卷
关键词：
Roflumilast; Chronic obstructive pulmonary disease; Lung function; Exacerbation; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of roflumilast on chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Shen, Lu-Fei
    Lv, Xiao-Dong
    Chen, Wen-Yu
    Yang, Qi
    Fang, Zhi-Xian
    Lu, Wei-Fen
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (03) : 731 - 738
  • [22] Effects of the Novel Inhaled Phosphodiesterase-4 (PDE4) Inhibitor CHF6001 in Targeting Markers of Inflammation in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
    Singh, D.
    Govoni, M.
    Beeh, K. M.
    Colgan, B.
    Kornmann, O.
    Leaker, B.
    Watz, H.
    Lucci, G.
    Geraci, S.
    Rocco, E. Calabro
    Emirova, A.
    Nandeuil, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
    Shang, Nan
    Liu, Yang
    Jin, Yueping
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [24] BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) HEALTHCARE COSTS IN PATIENTS WITH MODERATE-TO-SEVERE DISEASE
    Lubwama, R.
    Mayen, Herrera E.
    Petruski-Ivleva, N.
    Hawaldar, K.
    Madziva, D.
    Qureshi, T.
    Cheng, W. H.
    VALUE IN HEALTH, 2024, 27 (12) : S98 - S98
  • [25] Effectiveness of Roflumilast in Treating Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
    Naseem, Sumbal
    Hassan, Muhammad
    Akhtar, Shazia Nasim
    Syed, Fibhaa
    Khan, Naveed Ullah
    Usman, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [26] Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study
    Compton, CH
    Gubb, J
    Nieman, R
    Edelson, J
    Amit, O
    Bakst, A
    Ayres, JG
    Creemers, JPHM
    Schultze-Werninghaus, G
    Brambilla, C
    Barnes, NC
    LANCET, 2001, 358 (9278): : 265 - 270
  • [27] Safety and efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in moderate-to-severe chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Maya, T.
    Mathew, Alisha
    Raj, Elstin Anbu S.
    Vilakkathala, Rajesh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 395 - 396
  • [28] Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Fatima, Eeshal
    Rehman, Obaid Ur
    Nadeem, Zain Ali
    Akram, Umar
    Karamat, Riyan Imtiaz
    Larik, Muhammad Omar
    Fatima, Maurish
    Chitwood, Joshua
    Ahmad, Arslan
    Esposito, Sarah
    Nashwan, Abdulqadir J.
    RESPIRATORY INVESTIGATION, 2025, 63 (01) : 146 - 155
  • [29] Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic obstructive pulmonary disease: pooled analysis of the ENHANCE trials
    Mahler, Donald A.
    Bhatt, Surya P.
    Rheault, Tara
    Reyner, Daniel
    Bengtsson, Thomas
    Dixon, Amy
    Rickard, Kathleen
    Singh, Dave
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024,
  • [30] Effects of isolated cycle ergometer training on patients with moderate-to-severe chronic obstructive pulmonary disease
    Pitta, F
    Brunetto, AF
    Padovani, CR
    Godoy, I
    RESPIRATION, 2004, 71 (05) : 477 - 483
12345